Immune scores in colorectal cancer: Where are we? - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2020

Immune scores in colorectal cancer: Where are we?

Résumé

There is growing evidence that the immune system may prevent the occurrence, growth and metastatic diffusion of colorectal cancer (CRC). The role played by the adaptive immune response at the tumour site is critical in the balance between tumour invasion and defence against cancer. Recent data have shown that the evaluation of this immune response may help to define the prognosis and possibly the treatment of localised CRC as well as metastatic CRC. Tumour infiltrates with T cells (CD3+), cytotoxic T cells (CD8+) and memory T cells (CD45RO+) are the immune parameters most consistently and strongly associated with good clinical outcome in CRC. Several scoring systems have been developed, including the Immunoscore®, based on the immunohistochemical determination with a digital image analysis system of the density of CD3+ and CD8+ lymphocytes in the centre and the invasive margin of the tumour. This review will focus on the different immunoscoring systems developed in CRC, their performance, their limitations and their potential for improving patients’ care in the future.

Domaines

Cancer
Fichier principal
Vignette du fichier
S0959804920304767.pdf (4.66 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02998186 , version 1 (17-10-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

David Malka, Astrid Lièvre, Thierry André, Julien Taïeb, Michel Ducreux, et al.. Immune scores in colorectal cancer: Where are we?. European Journal of Cancer, 2020, 140, pp.105-118. ⟨10.1016/j.ejca.2020.08.024⟩. ⟨hal-02998186⟩
64 Consultations
186 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More